1. Home
  2. PCVX vs GBDC Comparison

PCVX vs GBDC Comparison

Compare PCVX & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • GBDC
  • Stock Information
  • Founded
  • PCVX 2013
  • GBDC 2009
  • Country
  • PCVX United States
  • GBDC United States
  • Employees
  • PCVX N/A
  • GBDC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • GBDC Finance: Consumer Services
  • Sector
  • PCVX Health Care
  • GBDC Finance
  • Exchange
  • PCVX Nasdaq
  • GBDC Nasdaq
  • Market Cap
  • PCVX 4.0B
  • GBDC 3.7B
  • IPO Year
  • PCVX 2020
  • GBDC 2010
  • Fundamental
  • Price
  • PCVX $45.93
  • GBDC $14.05
  • Analyst Decision
  • PCVX Strong Buy
  • GBDC Buy
  • Analyst Count
  • PCVX 7
  • GBDC 3
  • Target Price
  • PCVX $101.67
  • GBDC $15.00
  • AVG Volume (30 Days)
  • PCVX 1.3M
  • GBDC 1.5M
  • Earning Date
  • PCVX 11-04-2025
  • GBDC 11-18-2025
  • Dividend Yield
  • PCVX N/A
  • GBDC 11.41%
  • EPS Growth
  • PCVX N/A
  • GBDC N/A
  • EPS
  • PCVX N/A
  • GBDC 1.41
  • Revenue
  • PCVX N/A
  • GBDC $877,342,000.00
  • Revenue This Year
  • PCVX N/A
  • GBDC $23.63
  • Revenue Next Year
  • PCVX N/A
  • GBDC N/A
  • P/E Ratio
  • PCVX N/A
  • GBDC $9.92
  • Revenue Growth
  • PCVX N/A
  • GBDC 31.97
  • 52 Week Low
  • PCVX $27.66
  • GBDC $12.68
  • 52 Week High
  • PCVX $103.30
  • GBDC $16.01
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 63.80
  • GBDC 51.05
  • Support Level
  • PCVX $40.14
  • GBDC $13.70
  • Resistance Level
  • PCVX $45.90
  • GBDC $14.17
  • Average True Range (ATR)
  • PCVX 2.15
  • GBDC 0.20
  • MACD
  • PCVX -0.07
  • GBDC -0.00
  • Stochastic Oscillator
  • PCVX 98.26
  • GBDC 52.76

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.

Share on Social Networks: